Delivery Order SPE2DB20D1100-SPE2DB25FC5G1

Award Date 5/27/25
Potential Completion Date 5/28/25
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tolvaptan 15 mg tablets. The contract has a ceiling value of $7,674.04 and a period of performance running through March 4, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Tolvaptan 15 mg tablets, a medication, with a ceiling value of $32,564.52 and a completion date of May 21, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOLVAPTAN 15 MG TABLET UD 10S, a medication, with a ceiling value of $13,468.19 and a performance period ending on May 22, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,444.55 firm fixed price contract is for the delivery of 10-count units of the 30 mg Tolvaptan tablet medication. The delivery order has a completion date of May 22, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract...
The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TOLVAPTAN 30 MG TABLET UD 10S. The contract has a ceiling value of $39,561.01 and is set for completion on May 29, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle...
This federal contract award, valued at $24,520.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that provides Tolvaptan 15 mg tablets to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for the company to supply a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tolvaptan 30 mg tablets, a medication used to treat certain types of hyponatremia. The contract has a ceiling value of $18,592.99 and a period of performance through May 28, 2025. The contract is a firm-fixed-price type and is not set aside for any specific business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The $63,134.84 firm fixed-price contract is for the delivery of TOLVAPTAN 15 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen is the prime contractor and no set-aside designation was used. This contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $10,623.60 firm fixed-price delivery order contract is for the supply of SAMSCA 15 MG TABLET 10S, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2025 and was awarded on May 22, 2025. The award is not designated as a set-aside and represents an open competition....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,588.22, is for the delivery of amlodipine-valsartan 5-160 mg tablets in 30-count packages. The contract has an ultimate completion date of March 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC5G1
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tolvaptan 15 mg tablets. The contract has a ceiling value of $5,077.88 and a completion date of May 28, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for federal agencies, including the Defense Health Agency and U.S. Coast Guard, through December 2026.

Generated 8/31/25, 12:55 AM